Drug Profile
ALTU 139
Alternative Names: ALTU139Latest Information Update: 05 Sep 2006
Price :
$50
*
At a glance
- Originator Altus Pharmaceuticals
- Class
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Steatorrhoea
Most Recent Events
- 30 Mar 2006 Discontinued - Preclinical for Steatorrhoea in USA (PO)
- 19 Jul 2005 Preclinical trials in Steatorrhoea in USA (PO)
- 25 May 2004 Altus Biologics is now called Altus Pharmaceuticals